Literature DB >> 25965445

FibroScan® access in Canada: Time for reform, a call for universal access.

Sergio M Borgia.   

Abstract

Mesh：

Year:  2015        PMID： 25965445      PMCID： PMC4444034          DOI： 10.1155/2015/842080

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN： 2291-2789


× No keyword cloud information.
  12 in total

1.  Percutaneous liver biopsy practice patterns among Canadian hepatologists.

Authors:  Mohammed Aljawad; Eric M Yoshida; Julia Uhanova; Paul Marotta; Natasha Chandok
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

2.  Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.

Authors:  Giada Sebastiani; Peter Ghali; Phil Wong; Marina B Klein; Marc Deschenes; Robert P Myers
Journal:  Can J Gastroenterol Hepatol       Date:  2014-01

3.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

Authors:  Leonard B Seeff; Gregory T Everson; Timothy R Morgan; Teresa M Curto; William M Lee; Marc G Ghany; Mitchell L Shiffman; Robert J Fontana; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Clin Gastroenterol Hepatol       Date:  2010-04-01       Impact factor: 11.382

4.  Reduced mortality rates following elective percutaneous liver biopsies.

Authors:  Joe West; Timothy R Card
Journal:  Gastroenterology       Date:  2010-06-12       Impact factor: 22.682

5.  Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population.

Authors:  Grace L-H Wong; Vincent W-S Wong; Angel M-L Chim; Karen K-L Yiu; Shirley H-T Chu; Mia K-P Li; Henry L-Y Chan
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

6.  Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C.

Authors:  Silvia Skripenova; Thomas D Trainer; Edward L Krawitt; Hagen Blaszyk
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

7.  Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia.

Authors:  Victoria Yui-Min Kan; Vladimir Marquez Azalgara; Jo-Ann E Ford; W C Peter Kwan; Siegfried Roland Erb; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2015-03

8.  Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Authors:  Thierry Poynard; Mona Munteanu; Françoise Imbert-Bismut; Frederic Charlotte; Dominique Thabut; Sophie Le Calvez; Djamila Messous; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu
Journal:  Clin Chem       Date:  2004-06-10       Impact factor: 8.327

9.  An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.

Authors:  Josh J Carlson; Kris V Kowdley; Sean D Sullivan; Scott D Ramsey; David L Veenstra
Journal:  J Gastroenterol Hepatol       Date:  2009-04-23       Impact factor: 4.029

10.  Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations.

Authors:  Laurent Castéra; Juliette Foucher; Pierre-Henri Bernard; Françoise Carvalho; Daniele Allaix; Wassil Merrouche; Patrice Couzigou; Victor de Lédinghen
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425
View more
  1 in total

1.  A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.

Authors:  A Seaman; C A King; T Kaser; A Geduldig; W Ronan; R Cook; B Chan; X A Levander; K C Priest; P T Korthuis
Journal:  Int J Drug Policy       Date:  2021-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.